324 related articles for article (PubMed ID: 36130641)
1. Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review.
Zhai LY; Su AM; Liu JF; Zhao JJ; Xi XG; Hou XM
Int J Biol Macromol; 2022 Nov; 221():1476-1490. PubMed ID: 36130641
[TBL] [Abstract][Full Text] [Related]
2. G-Quadruplex Targeting in the Fight against Viruses: An Update.
Ruggiero E; Zanin I; Terreri M; Richter SN
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681641
[TBL] [Abstract][Full Text] [Related]
3. The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19.
Panera N; Tozzi AE; Alisi A
Drugs; 2020 Jul; 80(10):941-946. PubMed ID: 32451923
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression.
Razzaq M; Han JH; Ravichandran S; Kim J; Bae JY; Park MS; Kannappan S; Chung WC; Ahn JH; Song MJ; Kim KK
Arch Pharm Res; 2023 Jul; 46(7):598-615. PubMed ID: 37563335
[TBL] [Abstract][Full Text] [Related]
5. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
Bezzi G; Piga EJ; Binolfi A; Armas P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807682
[TBL] [Abstract][Full Text] [Related]
6. Targeting the RNA G-Quadruplex and Protein Interactome for Antiviral Therapy.
Zhai LY; Liu JF; Zhao JJ; Su AM; Xi XG; Hou XM
J Med Chem; 2022 Aug; 65(15):10161-10182. PubMed ID: 35862260
[TBL] [Abstract][Full Text] [Related]
7. Unlocking G-Quadruplexes as Antiviral Targets.
Abiri A; Lavigne M; Rezaei M; Nikzad S; Zare P; Mergny JL; Rahimi HR
Pharmacol Rev; 2021 Jul; 73(3):897-923. PubMed ID: 34045305
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.
Lavigne M; Helynck O; Rigolet P; Boudria-Souilah R; Nowakowski M; Baron B; Brülé S; Hoos S; Raynal B; Guittat L; Beauvineau C; Petres S; Granzhan A; Guillon J; Pratviel G; Teulade-Fichou MP; England P; Mergny JL; Munier-Lehmann H
Nucleic Acids Res; 2021 Jul; 49(13):7695-7712. PubMed ID: 34232992
[TBL] [Abstract][Full Text] [Related]
9. Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study.
Zheng BX; Yu J; Long W; Chan KH; Leung AS; Wong WL
Chem Commun (Camb); 2023 Feb; 59(11):1415-1433. PubMed ID: 36636928
[TBL] [Abstract][Full Text] [Related]
10. Targeting RNA G-Quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19?
Zhao C; Qin G; Niu J; Wang Z; Wang C; Ren J; Qu X
Angew Chem Int Ed Engl; 2021 Jan; 60(1):432-438. PubMed ID: 32939952
[TBL] [Abstract][Full Text] [Related]
11. G-Quadruplexes in the Viral Genome: Unlocking Targets for Therapeutic Interventions and Antiviral Strategies.
Pathak R
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005893
[TBL] [Abstract][Full Text] [Related]
12. Structure and Dynamics of RNA Guanine Quadruplexes in SARS-CoV-2 Genome. Original Strategies against Emerging Viruses.
Miclot T; Hognon C; Bignon E; Terenzi A; Marazzi M; Barone G; Monari A
J Phys Chem Lett; 2021 Oct; 12(42):10277-10283. PubMed ID: 34652910
[TBL] [Abstract][Full Text] [Related]
13. Unlocking G-Quadruplexes as Targets and Tools against COVID-19.
Qin G; Zhao C; Yang J; Wang Z; Ren J; Qu X
Chin J Chem; 2022 Dec; ():. PubMed ID: 36711116
[TBL] [Abstract][Full Text] [Related]
14. RNA G-quadruplex forming regions from SARS-2, SARS-1 and MERS coronoviruses.
Kabbara A; Vialet B; Marquevielle J; Bonnafous P; Mackereth CD; Amrane S
Front Chem; 2022; 10():1014663. PubMed ID: 36479439
[TBL] [Abstract][Full Text] [Related]
15. G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy.
Ruggiero E; Richter SN
Nucleic Acids Res; 2018 Apr; 46(7):3270-3283. PubMed ID: 29554280
[TBL] [Abstract][Full Text] [Related]
16. G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection.
Zareie AR; Dabral P; Verma SC
Pathogens; 2024 Jan; 13(1):. PubMed ID: 38251367
[TBL] [Abstract][Full Text] [Related]
17. RNA G-quadruplex formed in SARS-CoV-2 used for COVID-19 treatment in animal models.
Qin G; Zhao C; Liu Y; Zhang C; Yang G; Yang J; Wang Z; Wang C; Tu C; Guo Z; Ren J; Qu X
Cell Discov; 2022 Sep; 8(1):86. PubMed ID: 36068208
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of G-quadruplex in SARS-CoV-2 RNA by RHAU peptide.
Nguyen LTA; Nguyen TTT; Dang DT
Curr Res Struct Biol; 2024; 7():100126. PubMed ID: 38292819
[TBL] [Abstract][Full Text] [Related]
19. Methodological advances of bioanalysis and biochemical targeting of intracellular G-quadruplexes.
Teng X; Dai Y; Li J
Exploration (Beijing); 2022 Apr; 2(2):20210214. PubMed ID: 37323879
[TBL] [Abstract][Full Text] [Related]
20. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
